
Academic Journal
Q3Case Reports in Oncology
About Case Reports in Oncology
Case Reports in Oncology is a scholarly journal published by S. Karger AG. SCImago 2025 lists it in Q3, with an SJR of 0.302 and H-index of 30.
Coverage: 2010-2026. Research categories: Oncology (Q3).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-11-09. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Sarcoma Diagnosis and Treatment; Cancer Immunotherapy and Biomarkers; Cancer Diagnosis and Treatment; Neuroendocrine Tumor Research Advances; Lung Cancer Treatments and Mutations; Lymphoma Diagnosis and Treatment.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Long-term Clinical Benefit of Sacituzumab Govitecan in Metastatic HR+/HER2- Breast Cancer Despite Discordant Radiologic Progression over a 24-year course: A Case Report
Yilin Lin, Yongxia Dang, Xiaotong Li, Tong Li et al.
2026-09-30 · DOI: 10.1159/cro/abzag057Sustained clearance of circulating tumor DNA supports the de-escalation of first-line trastuzumab deruxtecan in a patient with metastatic HER2-positive breast cancer: case report
Fengting Yan, Philip Miller, Minetta C Liu
2026-09-30 · DOI: 10.1159/cro/abzag072Giant Clear Cell Renal Cell Carcinoma With Focal Chromophobe-like Morphology in a Young Adult Presenting With Gastrointestinal Symptoms: A Case Report
Salem Hakouk, Omar Al-Abed, Mohammad Alaa Aldakak, Anas Saad et al.
2026-09-30 · DOI: 10.1159/cro/abzag020Severe Refractory Immune Effector Cell-Associated Enterocolitis After Ciltacabtagene Autoleucel With Clonal Persistence of CAR-T Construct-Positive T Cells in the Gastrointestinal Tract: A Case Report
Hira Cheema, Syed Naqvi, Khadijah Adel Hassan Mahmoud Moustafa, Maurizio Zangari et al.
2026-09-29 · DOI: 10.1159/cro/abzag071Coexistence of a Retrorectal Tailgut Cyst and an Incidental Coccygeal Chordoma in a 20-Year-Old Woman: A Case Report
Niv Gronovich, Ofra Carmel, Victoria Doviner Sherman, Shlomo Yellinek et al.
2026-09-25 · DOI: 10.1159/cro/abzag065Primary Salivary Clear Cell Carcinoma with Response to Checkpoint Inhibition: Case Report and Review of the Literature
Samuel F. Schaeffer, Matthew M. Mirsky
2026-09-15 · DOI: 10.1159/000552473A Case Report of Bilateral Thyroid Thymic Carcinoma with Multiple Cervical Lymph Node Metastases: Clinical Manifestations and Imaging Characteristics
Xiaojuan Zheng, Zhuomin Chen
2026-08-19 · DOI: 10.1159/000551983Right-To-Left Stage Migration in Advanced Hepatocellular Carcinoma: A Case Report of a Successful Multimodal Approach
Anna Nappi, Rocco Morra, Sergio Facchini, Nicoletta Zanaletti et al.
2026-08-13 · DOI: 10.1159/000552976Long-Term Continuation therapy with Nab-Paclitaxel and Bevacizumab ± Anti-PD-1 in Advanced NSCLC: Case Reports and Mechanistic Insights:case report
Xiaofen Pan, Xueying Li, Jiehao Liao, Suhua Chen et al.
2026-08-13 · DOI: 10.1159/000551998Integrated Traditional Chinese and Western Medicine for Severe Tislelizumab-Induced Rash: A Case Report
Boya Wang, Yan Zhang, Jianglin Wu, Sicheng Yi et al.
2026-08-05 · DOI: 10.1159/000553623Pseudoprogression After Axi-cel in Primary Refractory PMBCL Following Failed Bridging: Case Report and Management Considerations
Philip Alan Speicher, Marie-Noelle Kronig, Urban Novak
2026-08-04 · DOI: 10.1159/000553567Carboplatin, Etoposide, and Durvalumab for Extensive-Stage Small Cell Lung Cancer in a Patient Undergoing Maintenance Hemodialysis: A Case Report
Morimi Fujita, Ninso Matsunaga, Hiroyuki Tsuji, Yosuke Tamura et al.
2026-08-04 · DOI: 10.1159/000552719Not All Neutrophilia Is Leukemia: Leukemoid Reaction Associated with MGUS Mimicking Chronic Neutrophilic Leukemia – A Case Report
Yousef Al-Asa'd, Aliaa Amer, Hesham ELSabah, Sarah A. Elkourashy et al.
2026-08-03 · DOI: 10.1159/000553625Synchronous Chronic Myeloid Leukemia and Metastatic Papillary Thyroid Carcinoma: A Case Report of a Diagnostic and Therapeutic Challenge
Nada SalahAldin Ishti, Nagham N. Alkhateeb, Khaled Alhashlamon, Shoroq Hamadneh et al.
2026-08-03 · DOI: 10.1159/000553529Retraction Statement
2026-07-31 · DOI: 10.1159/000553062Gemcitabine, Cisplatin, and Durvalumab for Alpha-Fetoprotein-Producing Cancer of Unknown Primary Suspected from the Biliary Tract: A Case Report
Kei Saito, Shuzo Nomura, Mariko Fujisawa, Mai Kitahara et al.
2026-07-23 · DOI: 10.1159/000553541Case Report: Rapid Improvement of Chronic Lymphocytic Leukemia Infiltration of the Scalp by BCL2-Inhibitor
Sike Esther Mbonde Mouangue, Dimitrios Deligkas, Dimitrios Vogdos, Maria Mainou et al.
2026-07-22 · DOI: 10.1159/000551956Long-Term Complete Response of Unresectable Small-Cell Neuroendocrine Carcinoma of the Gallbladder following Chemotherapy and Radiotherapy: A Case Report
Nidal Salim, Julia Vahabova, Kristina Tumanova, Daria Zvereva et al.
2026-07-22 · DOI: 10.1159/000553555Pathological Complete Response following Pembrolizumab Combined with Gemcitabine and Cisplatin Therapy for Initially Unresectable Intrahepatic Cholangiocarcinoma: A Case Report
Ikuo Nakamura, Naoto Takase, Kenjiro Iida, Mizuki Yoshida et al.
2026-07-21 · DOI: 10.1159/000553503Spontaneous Bilateral Perirenal Hemorrhage during Chemotherapy with Liposomal Paclitaxel and Cyclophosphamide in Breast Cancer: A Case Report
Lin Lv, Xiaohui Wang, Xiaotao Zhu
2026-07-21 · DOI: 10.1159/000553618Reviews
Community Reviews
Version History
October 2, 2026 at 10:02 pm
October 2, 2026